Clinical Trial Update: Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO

View source ↗

Summary

A completed clinical trial update on using new molecular markers to guide personalized therapy for ovarian cancer (the MEMENTO study).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Centro di Riferimento Oncologico - Aviano | Conditions: Ovarian Cancer | Status: COMPLETED